Endocrine, metabolic and cardioprotective effects of hexarelin in obese Zucker rats

Journal of Endocrinology

Volumn 166, Issue 3, 2000, Pages 529-536

  De Gennaro Colonna, V ^a   Rossoni, G ^a   Cocchi, D ^a   Rigamonti, A E ^a   Berti, F ^a   Muller, E E ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEXARELIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GLUCOSE INTOLERANCE; GROWTH HORMONE RELEASE; HEART PROTECTION; HYPERLIPIDEMIA; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT;

EID: 0033833604     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1660529     Document Type: Article

References (36)

1. Obesity-associated decrease in growth hormone-releasing hormone gene expression: A mechanism for reduced growth hormone mRNA levels in genetically obese Zucker rats
2. Plasma triglycerides in genetically obese rats
3. Effects of coadministered growth-hormone (GH)-releasing hormone and GH-releasing hexapeptide on maladaptive aspects of obesity in Zucker rats
4. Direct effects of corticotropin on plasma lipoprotein metabolism in man - Studies in vivo and in vitro
5. Defibrotide, an antithrombotic substance which prevents myocardial contracture in ischemic rabbit heart
6. Nonsteroidal anti-inflammatory drugs aggravate acute myocardial ischemia in the perfused rabbit heart: A role for prostacyclin
7. The effects of short and long term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance
8. The Zucker-fatty rat: A review
9. Radioimmunoassay for insulin-like growth factor-I: Solutions to some potential problems and pitfalls
10. Characterization of the hypothalamo-pituitary-IGF-I axis in rats made obese by overfeeding
11. Somatotropic dysfunction in growth hormone-releasing hormone-deprived neonatal rats: Effect of growth hormone replacement therapy
12. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
13. Growth hormone secretagogues stimulate the hypothalamic-pituitary-adrenal axis and are diabetogenic in the Zucker diabetic fatty rat
14. Growth hormone secretion is differently affected in genetically obese male and female rats
15. Worsening of ischemic damage in hearts from rats with selective growth hormone deficiency
16. Cardiac ischemia and impairment of vascular endothelium function in hearts from GH-deficient rats: Protection by hexarelin
17. GH-releasing activity of Hexarelin, a new growth hormone-releasing peptide, in infant and adult rats
18. Tissue concentration of somatomedin C: Further evidence for multiple sites of synthesis and paracrine or autocrine mechanism of action
19. Growth hormone and prolactin secretion in genetically obese Zucker rats
20. Growth hormone-releasing peptide-6 stimulates sleep, growth hormone, ACTH and cortisol release in normal man
21. Efficacy and specificity of 1-692,429, a novel nonpeptidyl growth hormone secretagogue, in beagles
22. Effect of early nutrition on adipose cellularity and pancreatic insulin release in the Zucker rat
23. Human pituitary growth hormone: Intrinsic lipolytic activity in rabbit fat cells
24. Growth hormone-independent cardioprotective effects of hexarelin in the rat
25. Hyperinsulinemia: A link between hypertension, obesity and glucose intolerance
26. Binding of hexarelin to human heart membranes
27. Binding of hexarelin to membranes from human heart and blood vessels
28. Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: An alternative to radioimmunoassay
29. In vitro and in vivo growth hormone responsiveness to growth hormone-releasing factor in male and female Zucker rats
30. Protectant activity of hexarelin or growth hormone against postischemic ventricular dysfunction in hearts from aged rats
31. Growth hormone and hexarelin prevent endothelial vasodilator dysfunction in aortic rings of the hypophysectomized rat
32. Plasma growth hormone concentration in the rat determined by radioimmunoassay
33. Modulation of pulsatile GH release through a novel receptor in hypothalamus and pituitary gland
34. Treatment of obese subjects with the oral growth hormone secretagogue MK-677 affects serum concentrations of several lipoproteins, but not lipoprotein(a)
35. Mechanisms of impaired growth hormone secretion in genetically obese Zucker rats: Role of growth hormone releasing factor and somatostatin
36. Hereditary obesity in the rat associated with high serum fat and cholesterol